Key points are not available for this paper at this time.
Our findings confirmed that hsacirc₀002130 served as a promotion role in osimertinib-resistant NSCLC.
Ma et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: